Letter to the EditorFull Access
Published Online:1 Mar 2000
- Cited by
- World Journal of Clinical Cases, Vol. 9, No. 20
- 31 August 2013 | Australasian Psychiatry, Vol. 22, No. 1
- 16 May 2011 | Therapeutic Advances in Psychopharmacology, Vol. 1, No. 2
- 2 February 2009 | British Journal of Pharmacology, Vol. 135, No. 6
- 13 March 2002 | Human Psychopharmacology: Clinical and Experimental, Vol. 17, No. 2
- YOSHIE MURAKAMI,
R.N., M.S.N. , - NOBUHISA GONDO,
M.D. , - HITOSHI OKAMURA,
M.D., PH.D. , - TATSUO AKECHI,
M.D., PH.D. , and - YOSUKE UCHITOMI,
M.D., PH.D. ,
1 November 2001 | American Journal of Psychiatry, Vol. 158, No. 11- YOSHIE MURAKAMI,
- ADAM KELLER ASHTON,
M.D. ,
1 November 2001 | American Journal of Psychiatry, Vol. 158, No. 11- ADAM KELLER ASHTON,
- PIERRE LANDRY,
M.D., PH.D., F.R.C.P.C. ,
1 November 2001 | American Journal of Psychiatry, Vol. 158, No. 11- PIERRE LANDRY,
- SANJAY J. MATHEW,
M.D. ,
1 June 2001 | American Journal of Psychiatry, Vol. 158, No. 6- SANJAY J. MATHEW,
- SCOTT D. MENDELSON,
M.D., PH.D. ,
1 June 2001 | American Journal of Psychiatry, Vol. 158, No. 6- SCOTT D. MENDELSON,
- VICTOR NAVARRO,
M.D. , - ALEX PONS,
M.D. , - ANA ROMERO,
PH.D. , and - MIGUEL BERNARDO,
M.D., PH.D. ,
1 June 2001 | American Journal of Psychiatry, Vol. 158, No. 6- VICTOR NAVARRO,